Effective April 21:
Naproxen sodium 220 mg per oral dosage unit (when sold in products labeled with a recommended maximum daily dose of 440 mg, and in package sizes exceeding 6,600 mg) is now Schedule III (changed from Schedule II).
CQI+ program now in effect
February 10, 2026
All requirements of ACP’s continuous quality improvement program for community pharmacies must be in place.
Read more ➞
